FTC chief calls for a ban on generic pay-for-delay deals
In a speech to the Center for American Progress, Leibowitz said eliminating such agreements could save $35 billion in healthcare costs over 10 years.
“From my perspective, … the decision about whether to restrict pay-for-delay settlements should be simple,” Leibowitz declared. “On the one hand you have savings to American consumers of $35 billion or more over 10 years, about $12 billion of which would be savings to the federal government, and the prospect of helping to pay for healthcare reform as well as the ability to set a clear national standard to stop anti-competitive conduct. On the other hand, you have a permissive legal regime that allows competitors to make collusive deals on the backs of consumers.”